HCPCS Level II code J1460 designates a single intramuscular injection of gamma globulin (1 cc). This code matters nationally because immunoglobulin products are used across multiple clinical indications—such as passive immunization and certain immune-mediated conditions—and are commonly billed in outpatient and ambulatory care settings. Payers apply distinct coverage policies and payment edits for injectable biologics, making accurate coding important for clinical documentation and claims processing.

Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarks on how this service is billed and reimbursed across major payers, a summary of clinical context for intramuscular immune globulin administration, and notes on common billing considerations. The publication highlights where national payment policies and coverage guidance intersect with clinical use, without state-level specificity. Data not available in the input for payer-specific reimbursement rates, associated taxonomies, and ICD-10 diagnoses are omitted from this summary.